Masaaki Ishikawa Selected Research

Hidden Hearing Loss

1/2019

Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaaki Ishikawa Research Topics

Disease

15	Neoplasms (Cancer) 08/2014 - 05/2004
9	Leukemia 09/2012 - 07/2003
5	B-Cell Leukemia (Leukemia, B Cell) 10/2013 - 05/2008
4	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2010
2	Pain (Aches) 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2014 - 11/2013
2	Lymphoma (Lymphomas) 01/2013 - 12/2005
2	Infections 05/2011 - 03/2002
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2007 - 05/2004
1	Adenoma (Adenomas) 04/2020
1	Ototoxicity 01/2019
1	Hidden Hearing Loss 01/2019
1	Thrombosis (Thrombus) 08/2016
1	Hemophilia B (Haemophilia B) 08/2016
1	Obesity 02/2015
1	Sensorineural Hearing Loss 05/2014
1	Noise-Induced Hearing Loss (Acoustic Trauma) 05/2014
1	Hearing Loss (Hearing Impairment) 05/2014
1	Down Syndrome (Down's Syndrome) 01/2013
1	Cerebral Palsy (Spastic Diplegia) 01/2013
1	Intellectual Disability (Idiocy) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	T-Cell Leukemia (Leukemia, T Cell) 01/2012
1	Carcinogenesis 02/2011
1	Hematuria 01/2011
1	Hemoptysis 01/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Cleft Lip (Harelip) 06/2010

Drug/Important Bio-Agent (IBA)

4	FlavonoidsIBA 01/2012 - 03/2005
4	Pharmaceutical PreparationsIBA 01/2011 - 06/2004
4	AntimetabolitesIBA 11/2007 - 06/2004
4	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2007 - 06/2004
3	papuamineIBA 08/2014 - 01/2013
3	caffeic acidIBA 02/2013 - 12/2005
3	Propolis (Bee Bread)IBA 08/2008 - 05/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2004 - 07/2003
2	EnzymesIBA 02/2015 - 01/2011
2	Docosahexaenoic AcidsIBA 01/2015 - 02/2011
2	caffeic acid undecyl esterIBA 10/2013 - 02/2013
2	EstersIBA 10/2013 - 08/2008
2	AlbuminsIBA 01/2013 - 02/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 09/2012 - 05/2012
2	spiruchostatin BIBA 09/2012 - 05/2012
2	Histone Deacetylase InhibitorsIBA 09/2012 - 05/2012
2	AntioxidantsIBA 01/2012 - 08/2008
2	cytochrome P-450 CYP4B1 (CYP4B1)IBA 01/2011 - 09/2008
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2011 - 02/2008
2	3,4,5-trihydroxybenzamidoximeIBA 03/2008 - 05/2007
2	naringeninIBA 10/2006 - 03/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2006 - 01/2006
2	naringinIBA 01/2006 - 03/2005
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	apramycinIBA 01/2019
1	gentamicin CIBA 01/2019
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2019
1	AminoglycosidesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Neomycin FDA LinkGeneric 01/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019
1	Hemostatics (Antihemorrhagics)IBA 08/2016
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 08/2016
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 02/2015
1	pifithrinIBA 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2014
1	JNK Mitogen-Activated Protein KinasesIBA 08/2014
1	calpain inhibitor IIIIBA 05/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2013
1	caffeic acid phenethyl esterIBA 02/2013
1	Midazolam (Versed)FDA LinkGeneric 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 01/2013
1	ChromatinIBA 01/2013
1	Propofol (Diprivan)FDA LinkGeneric 01/2013
1	AlkaloidsIBA 01/2013
1	AndrogensIBA 01/2013
1	Warfarin (Coumadin)FDA LinkGeneric 01/2013
1	Nitrous Oxide (Laughing Gas)IBA 01/2013
1	haliclonadiamineIBA 01/2013
1	Messenger RNA (mRNA)IBA 05/2012
1	acacetinIBA 01/2012
1	CaspasesIBA 01/2012
1	Fish OilsIBA 02/2011
1	AcidsIBA 02/2011
1	Small Interfering RNA (siRNA)IBA 02/2011
1	Factor V (Coagulation Factor V)IBA 01/2011
1	CarcinogensIBA 01/2011
1	glutathione S-transferase M1IBA 01/2011
1	glutathione S-transferase T1IBA 01/2011
1	SulfotransferasesIBA 01/2011

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 08/2014 - 11/2007
1	Tonsillectomy 01/2022
1	Reoperation 04/2020
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2016
1	Perioperative Period 08/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2016
1	Therapeutics 08/2016
1	Thyroidectomy 06/2011
1	Replantation 05/2011
1	Nasoalveolar Molding 06/2010